Synchronous Breast and Cervical Carcinoma: A Genetic Point of View

Synchronous Breast and Cervical Carcinoma: A Genetic Point of View

Breast carcinoma is the most common cancer of women in Malaysia. The most common sites of metastasis are the lung, liver, bone and brain. A 45-year-old lady was diagnosed with left invasive breast carcinoma stage IV (T4cN1M1) with axillary lymph nodes and lung metastasis. She was noted to have a cer...

Full description

Bibliographic Details
Main Authors:	Maya Mazuwin Yahya, Mohd Pazudin Ismail, Shogeta Ramanathan, Muhammad Nashriq Kadir, Azzahra Azhar, Noorul Balqis Che Ibrahim, Chee Lee Wee, Zahiah Mohd Amin, Seng Kong Tham, Shuhaila Mat-Sharani, Nik Soriani Yaacob
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Biomedicines
Subjects:	metastatic breast cancer cervical cancer concurrent chemoradiotherapy gene expression profiling
Online Access:	https://www.mdpi.com/2227-9059/11/2/525

Similar Items

Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer
by: Satomi Hattori, et al.
Published: (2021-04-01)

Dynamic Nomogram Based on the Metastatic Number and Sites and Therapy Strategies Predicting the Prognosis of Patients with Metastatic Cervical Cancer
by: Ma Y, et al.
Published: (2022-12-01)

Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
by: Chun Ho Kyung, et al.
Published: (2011-05-01)

Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
by: Raminta Stuopelytė, et al.
Published: (2023-04-01)

Role of addition of chemotherapy to palliative radiotherapy protocol: A review of literature and experience from a tertiary cancer center of India
by: Pavan Deepak Mandigala Venkata Ramana, et al.
Published: (2023-01-01)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
by: Hyun Hwan Sung, et al.
Published: (2022-03-01)

A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
by: Chen Li, et al.
Published: (2019-04-01)

Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy
by: Xin Li, et al.
Published: (2023-10-01)

Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses
by: Pei‐Wei Shueng, et al.
Published: (2023-01-01)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
by: Akihiko Wakayama, et al.
Published: (2017-08-01)

Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
by: Yuanxiu Yin, et al.
Published: (2022-07-01)

Quality of life (QOL) in patients suffering from locally advancedstage nasopharyngeal cancer before, during and after receiving carboplatin with concurrent chemoradiotherapy
by: Kanyarat Chuchart, et al.
Published: (2010-06-01)

Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
by: Ji‐An Liang, et al.
Published: (2020-09-01)

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy
by: Fraunholz Ingeborg, et al.
Published: (2012-06-01)

Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
by: Weiwei Li, et al.
Published: (2023-03-01)

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy
by: Magdalena Zaborowska-Szmit, et al.
Published: (2021-09-01)

The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World Results
by: Tzu-Ting Huang, et al.
Published: (2022-05-01)

Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy
by: Xiaojie Xia, et al.
Published: (2022-09-01)

RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy
by: Cheng Ming, et al.
Published: (2023-10-01)

Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study
by: Song Guan, et al.
Published: (2023-07-01)

Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis
by: Hee Kyung Kim, et al.
Published: (2019-09-01)

Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma
by: Yuting Huang, et al.
Published: (2022-12-01)

Outcome of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in non-metastatic locally advanced non-small cell lung cancer – A prospective and randomized study
by: Subir Pal, et al.
Published: (2023-01-01)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
by: Haonan Liu, et al.
Published: (2022-12-01)

The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2018-08-01)

Long Term Clinical Outcome and Late Toxicity of Intensity Modulated Versus Conventional Pelvic Radiation Therapy for Locally Advanced Cervix Carcinoma
by: Ajeet Kumar Gandhi, et al.
Published: (2019-03-01)

Meningitis caused by Listeria monocytogenes in a locally advanced cervical cancer patient with pyometra: A case report
by: Yusuke Matoba, et al.
Published: (2021-08-01)

Impact of induction chemotherapy with concurrent chemoradiotherapy on nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials
by: Ting-Chieh Huang, et al.
Published: (2022-09-01)

Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study
by: Yoko Kashima, et al.
Published: (2023-02-01)

The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
by: Min Chen, et al.
Published: (2023-04-01)

Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum
by: Yuko Kaneyasu, et al.
Published: (2019-04-01)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
by: Qiuji Wu, et al.
Published: (2021-10-01)

The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin
by: Igor Sirák, et al.
Published: (2008-01-01)

The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
by: Busra Yilmaz, et al.
Published: (2023-04-01)

The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients
by: Efsun Somay, et al.
Published: (2024-01-01)

Prospective randomized comparative study between EBRT alone and EBRT with ILRT boost in locally advanced unresectable esophageal cancer - Tertiary rural Indian cancer center experience
by: Pinky Sarahiya, et al.
Published: (2024-03-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy
by: Soo-Yoon Sung, et al.
Published: (2022-08-01)

Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer: Analysis by Radiation Phase and Histologic Type
by: Jun-Hyeok Kang, et al.
Published: (2020-10-01)

Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision
by: Chao-Hung Wang, et al.
Published: (2022-06-01)